Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
FDA panel's ruling on ultrasound system for renal denervation | Beloved cardiologist remembered by colleagues
Thursday, August 24, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

FDA panel votes in favor of Recor Medical renal denervation system

A few members of the panel did question the device's efficacy and long-term durability. The FDA will now use these findings to make its final decision related to the system's approval. 

READ MORE >
The U.S. Food and Drug Administration (FDA) has approved Recor Medical’s Paradise Ultrasound Renal Denervation (RDN) system for uncontrolled hypertension. The Recor system gained FDA clearance in November 2023.
Share on Twitter Share on Facebook Share on Linkedin

FDA panel votes in favor of Recor Medical renal denervation system

Share on Twitter Share on Facebook Share on Linkedin
The U.S. Food and Drug Administration (FDA) has approved Recor Medical’s Paradise Ultrasound Renal Denervation (RDN) system for uncontrolled hypertension. The Recor system gained FDA clearance in November 2023.
A few members of the panel did question the device's efficacy and long-term durability. The FDA will now use these findings to make its final decision related to the system's approval. 
READ MORE >

Beloved cardiologist Albert Waldo remembered for his lasting impact on electrophysiology

Waldo was a founding member of the North American Society of Pacing and Electrophysiology, which is now known as the Heart Rhythm Society, and was revered for his helpfulness and kindness.

READ MORE >
candles funeral dead respect
Share on Twitter Share on Facebook Share on Linkedin

Beloved cardiologist Albert Waldo remembered for his lasting impact on electrophysiology

Share on Twitter Share on Facebook Share on Linkedin
candles funeral dead respect
Waldo was a founding member of the North American Society of Pacing and Electrophysiology, which is now known as the Heart Rhythm Society, and was revered for his helpfulness and kindness.
READ MORE >

Featured Articles

TAVR safe and effective for severe AS patients with a very low gradient

Yes, all-cause cause mortality is higher among TAVR patients with a very low baseline gradient, but the difference is almost entirely due to those patients presenting with more comorbidities. 

READ MORE >
A TAVR procedure being performed at Northwestern Medicine in Chicago.
Share on Twitter Share on Facebook Share on Linkedin

TAVR safe and effective for severe AS patients with a very low gradient

Share on Twitter Share on Facebook Share on Linkedin
A TAVR procedure being performed at Northwestern Medicine in Chicago.
Yes, all-cause cause mortality is higher among TAVR patients with a very low baseline gradient, but the difference is almost entirely due to those patients presenting with more comorbidities. 
READ MORE >

Interventional echocardiography expected to grow thanks to new structural heart procedures

American Society of Echocardiography (ASE) President Stephen Little, MD, says there will be an increasing need for interventional echocardiographers in the near future.

READ MORE >
Video of ASE President Stephen Little, MD, discussing trends in interventional echo at the ASE 2023 annual meeting.
Share on Twitter Share on Facebook Share on Linkedin

Interventional echocardiography expected to grow thanks to new structural heart procedures

Share on Twitter Share on Facebook Share on Linkedin
Video of ASE President Stephen Little, MD, discussing trends in interventional echo at the ASE 2023 annual meeting.
American Society of Echocardiography (ASE) President Stephen Little, MD, says there will be an increasing need for interventional echocardiographers in the near future.
READ MORE >

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.

READ MORE >
pills-384846_960_720.jpg
Share on Twitter Share on Facebook Share on Linkedin

Missed opportunities: Many high-risk patients still not taking aspirin to prevent CVD

Share on Twitter Share on Facebook Share on Linkedin
pills-384846_960_720.jpg
Aspirin is known to be an effective, affordable way to prevent cardiovascular disease.
READ MORE >

In Case You Missed It

Alternative TAVR techniques: How to proceed when transfemoral access is not recommended

A team of researchers from the United States and Sweden explored data from nearly 12,000 TAVR patients for a new systematic review and meta-analysis. 

READ MORE >
Alternative access approaches for transcatheter aortic valve replacement (TAVR) procedures. courtesy of Interventional Cardiology Review 2018;13(3):145–50.
Share on Twitter Share on Facebook Share on Linkedin

Alternative TAVR techniques: How to proceed when transfemoral access is not recommended

Share on Twitter Share on Facebook Share on Linkedin
Alternative access approaches for transcatheter aortic valve replacement (TAVR) procedures. courtesy of Interventional Cardiology Review 2018;13(3):145–50.
A team of researchers from the United States and Sweden explored data from nearly 12,000 TAVR patients for a new systematic review and meta-analysis. 
READ MORE >

Microplastics identified in heart tissue samples—are surgeries to blame?

Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination. 

READ MORE >
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Share on Twitter Share on Facebook Share on Linkedin

Microplastics identified in heart tissue samples—are surgeries to blame?

Share on Twitter Share on Facebook Share on Linkedin
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination.  Surgeons Operating On Patient
Tiny fragments of plastic are commonly found deep inside the human body. Heart surgery, it seems, is one of many ways these microplastics are reaching their destination. 
READ MORE >

In Other News

Rad AI announces new artificial intelligence-powered software for radiology reports

After previewing the new software in September, Rad AI will make it commercially available throughout the United States at RSNA 2023 in Chicago.

READ MORE >
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
Share on Twitter Share on Facebook Share on Linkedin

Rad AI announces new artificial intelligence-powered software for radiology reports

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence robot evaluates healthcare data. Novo Nordisk announced a new collaboration with Valo Health, a healthcare technology company focused on using artificial intelligence (AI) technology to identify new drug treatments for cardiovascular disease (CVD).
After previewing the new software in September, Rad AI will make it commercially available throughout the United States at RSNA 2023 in Chicago.
READ MORE >

New AI model helps radiologists ID breast cancer lesions on ultrasound images

Using the new-look algorithm consistently improved reader accuracy, especially among less experienced radiologists. It also helped limit false-positive results. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

New AI model helps radiologists ID breast cancer lesions on ultrasound images

Share on Twitter Share on Facebook Share on Linkedin
Using the new-look algorithm consistently improved reader accuracy, especially among less experienced radiologists. It also helped limit false-positive results. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup